[Federal Register Volume 60, Number 129 (Thursday, July 6, 1995)]
[Notices]
[Pages 35225-35226]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-16619]



-----------------------------------------------------------------------


DEPARTMENT OF JUSTICE

Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.43(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on March 17, 1995, Penick 
Corporation, 158 Mount Olivet Avenue, Newark, New Jersey 07114, made 
application to the Drug Enforcement Administration (DEA) for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed below:

------------------------------------------------------------------------
                            Drug                               Schedule 
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)...............................           I 
Dihydromorphine (9145).....................................           I 
Pholcodine (9314)..........................................           I 
Cocaine (9041).............................................          II 
Codeine (9050).............................................          II 
Dihydrocodeine (9120)......................................          II 

[[Page 35226]]
                                                                        
Oxycodone (9143)...........................................          II 
Hydromorphone (9150).......................................          II 
Diphenoxylate (9170).......................................          II 
Benzoylecgonine (9180).....................................          II 
Ethylmorphine (9190).......................................          II 
Hydrocodone (9193).........................................          II 
Meperidine (9230)..........................................          II 
Methadone (9250)...........................................          II 
Methadone-intermediate (9254)..............................          II 
Dextropropoxyphene, bulk (non-dosage forms) (9273).........          II 
Morphine (9300)............................................          II 
Thebaine (9333)............................................          II 
Opium extracts (9610)......................................          II 
Opium fluid extract (9620).................................          II 
Opium tincture (9630)......................................          II 
Opium powdered (9639)......................................          II 
Opium granulated (9640)....................................          II 
Levo-alphacetylmethadol (9648).............................          II 
Oxymorphone (9652).........................................          II 
Alfentanil (9737)..........................................          II 
Sufentanil (9740)..........................................          II 
Fentanyl (9801)............................................          II 
------------------------------------------------------------------------



    The firms plan to manufacture the listed controlled substances for 
distribution as bulk pharmaceutical products to its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the above application and may also file a written 
request for a hearing thereon in accordance with 21 CFR 1301.54 and in 
the form prescribed by 21 CFR 1316.47.
    Any such comments, objections, or requests for a hearing may be 
addressed to the Deputy Assistant Administrator, Office of Diversion 
Control, Drug Enforcement Administration, United States Department of 
Justice, Washington, D.C. 20537, Attention: DEA Federal Register 
Representative (CCR), and must be filed no later than August 7, 1995.

    Dated: June 29, 1995.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 95-16619 Filed 7-5-95; 8:45 am]
BILLING CODE 4410-09-M